Zobrazeno 1 - 10 of 30 pro vyhledávání: '"Maria Soroka-Wojtaszko"'
1
Akademický článek
Extramedullary plasmacytoma diagnosed by fine needle aspiration and flow cytometry – case report
Autor: Katarzyna Karwicka, Olga Czabak, Magdalena Kozioł, Aneta Szudy-Szczyrek, Aneta Gorący, Maria Soroka-Wojtaszko, Marek Hus
Publikováno v: Journal of Education, Health and Sport, Vol 9, Iss 4, Pp 507-512 (2019)
The case report presents a patient with multiple myeloma (IgA κ type stage IIIA Durie Salmon stage, with ISS3) diagnosed. The patient had a progressive disease in the direction of extramedullary plasmacytoma. The clinical problem during treatment wa
Externí odkaz: https://doaj.org/article/083e280b5aad4d07ba89951aa26eac47
Zobrazit plný text záznamu
3
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
Autor: Ella Willenbacher, Zita Borbényi, Steffen Koschmieder, Robert Kralovics, Mario Cazzola, Uwe Platzbecker, Emanuil Gheorghita, Pencho Georgiev, Heinz Gisslinger, Mathieu Puyade, Malgorzata Calbecka, Jerome Rey, Kurt Krejcy, Jiri Mayer, Krzysztof Warzocha, Emilie Cayssials-Caylus, Veronika Buxhofer-Ausch, János Jakucs, Anna Vallova, Georgi Mihaylov, Hans Carl Hasselbalch, Lydia Roy, Vera Yablokova, Olga Cerna, Aleksander Skotnicki, Richard Greil, Jiri Schwarz, Vera Stoeva, Lylia Sivcheva, Zvenyslava Masliak, Halyna Pylypenko, Antonia Hatalova, Delia Dima, Jose Miguel Torregrosa-Diaz, Elena Volodicheva, Jean-Jacques Kiladjian, S V Klymenko, Carlos Besses Raebel, Polina Kaplan, Irina Sokolova, Horia Bumbea, Miklos Egyed, Nicoleta Berbec, Barbara Grohmann-Izay, Alexander Myasnikov, Petr Dulicek, Tamila Lysa, Dominik Wolf, Andrei Cucuianu, Christoph Klade, Mihaela Lazaroiu, Maria Soroka-Wojtaszko, Tamás Masszi, Ernst Forjan, Liana Gercheva-Kyuchukova, Franz Bauer, Dorota Krochmalczyk, Árpád Illés, Mikulas Hrubisko, Jolanta Starzak-Gwozdz, Viktor Rossiev
Publikováno v: The Lancet Haematology. 7:e196-e208
Summary Background The PROUD-PV and CONTINUATION-PV trials aimed to compare the novel monopegylated interferon ropeginterferon alfa-2b with hydroxyurea, the standard therapy for patients with polycythaemia vera, over 3 years of treatment. Methods PRO
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef767894c3f5dbd8084e8e09eb738e2f
https://doi.org/10.1016/s2352-3026(19)30236-4
Zobrazit plný text záznamu
6
New prognostic biomarkers in multiple myeloma
Autor: Maria Soroka-Wojtaszko, Aneta Szudy-Szczyrek, Marek Hus, Michał Szczyrek
Publikováno v: Postępy Higieny i Medycyny Doświadczalnej, Vol 70, Pp 811-819 (2016)
Multiple myeloma is a malignant neoplastic disease, characterized by uncontrolled proliferation and accumulation of plasma cells in the bone marrow, which is usually connected with production of a monoclonal protein. It is the second most common hema
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fbfe7d0a514e1351c3ebbb179ff10d
https://doi.org/10.5604/17322693.1211183
Zobrazit plný text záznamu
7
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
Autor: Joanna Mańko, Aleksander B. Skotnicki, Andrzej Hellmann, Iwona Hus, K. Sulek, Tadeusz Robak, Hanna Ciepluch, Maria Soroka-Wojtaszko, Dariusz Jawniak, Anna Dmoszynska, Lech Konopka, Janusz Kloczko, Marek Hus, Teresa Wolska-Smolen
Publikováno v: British Journal of Cancer
Multiple myeloma (MM) is a plasma cell malignancy characterised by the accumulation of long-lasting plasma cells in the bone marrow and/or extramedullar sites. Conventional chemotherapy produces an overall response rate of 40–60% with a median surv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49677c924e5f4452a7ef84f6b56085a7
https://doi.org/10.1038/sj.bjc.6602225
Zobrazit plný text záznamu
8
Production of Proangiogenic Cytokines During Thalidomide Treatment of Multiple Myeloma
Autor: Jacek Roliński, Agnieszka Bojarska-Junak, Maria Soroka-Wojtaszko, Damian Domański, Marek Hus, Anna Dmoszynska
Publikováno v: Leukemia & Lymphoma. 43:401-406
Recently a growing number of studies have suggested the efficacy of thalidomide (THAL) in the treatment of relapsed or resistant multiple myeloma. Some of these studies indicate that the thalidomide antimyeloma effect is associated with decreased ves
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a20f474cefc4ec96bb8f96a73f848cf
https://doi.org/10.1080/10428190290006224
Zobrazit plný text záznamu
10
Clinical and Biological Role of Accumulation of the NPM-1 Splice Variant R2 in AML, MDS and sAML
Autor: Grazyna Stasiak, Lars Bullinger, Olga Jankowska-Lecka, Bożena Sokołowska, Tomasz Gromek, Andrzej Stepulak, Joanna Zaleska, Malgorzata Zajac, Marek Hus, Michał Kiełbus, Norbert Grzasko, Aneta Szudy-Szczyrek, Krzysztof Giannopoulos, Jakub Czapinski, Maria Soroka-Wojtaszko
Publikováno v: Blood. 128:2878-2878
Background Acute myelogenous leukemia (AML) represents a heterogeneous group of myeloid malignancies harboring different chromosomal abnormalities, gene mutations, and epigenetic modifications. Recent clinical and biological studies indicate that mye
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c09d07b626c121f34c505b8155ba46a6
https://doi.org/10.1182/blood.v128.22.2878.2878
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje